The specific survival status of gastric mesenchymal tumor after surgery should be based on the patient’s own physical condition, tumor stage and whether metastasis occurs and other factors for comprehensive reference, some of which can be long-term survival. Generally speaking, the earlier detection, diagnosis and treatment are more favorable to the long-term survival of patients. Patients with primary gastric mesenchymal tumor without metastasis are expected to survive for a long time through thorough resection surgery. It has some relationship with the following factors: 1. The patient’s own physical condition: if the patient has no underlying diseases and diseases of heart, lungs, kidneys and other important organs, the overall survival condition is generally better. 2. Tumor stage: if the patient belongs to high-risk gastrointestinal mesenchymal stromal tumors, the recurrence and metastasis rate after surgery will be higher, which will directly affect the survival of the patient. 3. Metastasis: for primary gastric mesenchymal tumor patients, without metastasis, after thorough resection and surgery, it is expected to survive for a long time, for patients who have metastasis or cannot undergo surgery, generally through targeted drug therapy can also effectively prolong the survival period. It should be noted that patients with gastric mesenchymal tumor can reduce the adverse effects of the disease through “early detection, early diagnosis, early treatment”, and many of them may survive for a long time, so it is recommended that patients establish confidence in treatment.